A novel role for PSD-95 in mediating ethanol intoxication, drinking and place preference.
A novel role for PSD-95 in mediating ethanol intoxication, drinking and place preference.
复制标题
DOI:
10.1111/j.1369-1600.2010.00282.x
复制
发表时间:
2011-07
影响因子:
3.4
通讯作者:
Holmes A
中科院分区:
文献类型:
--
作者:
Camp MC;Feyder M;Ihne J;Palachick B;Hurd B;Karlsson RM;Noronha B;Chen YC;Coba MP;Grant SG;Holmes A
The synaptic signaling mechanisms mediating the behavioral effects of ethanol (EtOH) remain poorly understood. Post-synaptic density 95 (PSD-95, SAP-90, Dlg4) is a key orchestrator of N-methyl-D-aspartate receptors (NMDAR) and glutamatergic synapses, which are known to be major sites of EtOH’s behavioral actions. However, the potential contribution of PSD-95 to EtOH-related behaviors has not been established. Here, we evaluated knockout (KO) mice lacking PSD-95 for multiple measures of sensitivity to the acute intoxicating effects of EtOH (ataxia, hypothermia, sedation/hypnosis), EtOH drinking under conditions of free access and following deprivation, acquisition and long-term retention of EtOH conditioned place preference (CPP) (and lithium chloride-induced conditioned taste aversion), and intoxication-potentiating responses to NMDAR antagonism. PSD-95 KO exhibited increased sensitivity to the sedative/hypnotic, but not ataxic or hypothermic, effects of acute EtOH relative to wild-type controls (WT). PSD-95 KO consumed less EtOH than WT, particularly at higher EtOH concentrations, although increases in KO drinking could be induced by concentration-fading and deprivation. PSD-95 KO showed normal EtOH CPP 1 day after conditioning, but showed significant aversion 2 weeks later. Lithium chloride-induced taste aversion was impaired in PSD-95 KO at both time points. Finally, the EtOH-potentiating effects of the NMDAR antagonist MK-801 were intact in PSD-95 KO at the dose tested. These data reveal a major, novel role for PSD-95 in mediating EtOH behaviors, and add to growing evidence that PSD-95 is a key mediator of the effects of multiple abused drugs.
登录
查看更多内容
DOI:
10.1523/jneurosci.4904-07.2008
发表时间:
2008-08-06
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Hefner K;Whittle N;Juhasz J;Norcross M;Karlsson RM;Saksida LM;Bussey TJ;Singewald N;Holmes A
通讯作者:
Holmes A
影响因子:
2.9
作者:
Boyce-Rustay, Janel M.;Cameron, Heather A.;Holmes, Andrew
通讯作者:
Holmes, Andrew
影响因子:
3.4
作者:
Karlsson, Rose-Marie;Hefner, Kathryn R.;Sibley, David R.;Holmes, Andrew
通讯作者:
Holmes, Andrew
影响因子:
9.9
作者:
Fernandez, Esperanza;Collins, Mark O.;Uren, Rachel T.;Kopanitsa, Maksym V.;Komiyama, Noboru H.;Croning, Mike D. R.;Zografos, Lysimachos;Armstrong, J. Douglas;Choudhary, Jyoti S.;Grant, Seth G. N.
通讯作者:
Grant, Seth G. N.
DOI:
10.1176/appi.ajp.2010.10040484
发表时间:
2010-12
期刊:
The American journal of psychiatry
影响因子:
--
作者:
Feyder M;Karlsson RM;Mathur P;Lyman M;Bock R;Momenan R;Munasinghe J;Scattoni ML;Ihne J;Camp M;Graybeal C;Strathdee D;Begg A;Alvarez VA;Kirsch P;Rietschel M;Cichon S;Walter H;Meyer-Lindenberg A;Grant SG;Holmes A
通讯作者:
Holmes A